Navigation Links
ChanTest Announces a Global Campaign to Share New Findings and Developments in Cystic Fibrosis Research

Cleveland, OH (PRWEB) September 11, 2013

The world is still looking for meaningful solutions to address the pain and suffering of patients with Cystic Fibrosis. On Thursday, September 12, ChanTest will be hosting a complimentary webinar entitled “Unfolding Cystic Fibrosis Research,” to share important information in this field.

The event will include presentations by Dr. Jinliang Sui, Senior Director of High Throughput Screening and Bioinformatics at Flatley Discovery Lab, where they are seeking a Cure for Cystic Fibrosis, and Dr. Anthony Lacerda, Director of Contract Research and Development at ChanTest.

Dr. Sui will discuss efforts at Flatley Discovery Lab to advance high throughput screening for CFTR modulators (cystic fibrosis transmembrane conductance regulator) using human epithelial (skin) cells. Scientists there have identified novel and efficacious drugs called CFTR modulators, which they are planning to take into clinical trials to be evaluated for patients.

Dr. Lacerda will then present data from the ChanTest Ussing Chamber Assay (UCA) research. This research allows scientists like Dr. Sui at Flatley Discovery Lab to assess a new drug’s effects on proteins such as CFTR. This expedites the process of finding the best new drug compounds because the ChanTest Ussing Chamber Assay provides faster answers, and more accurate answers.

“In a cystic fibrosis (CF) patient, the CF gene tells the individual’s epithelial cells to produce a defective version of the CFTR (cystic fibrosis transmembrane conductance regulator) protein, which then causes the fluid and mucus found in cells that line the lungs (and other organs) to become thickened and sticky,” said Dr. Lacerda of ChanTest. “By being able to identify the best drug candidates that can have an effect on CFTR, through the Ussing Chamber Assay from ChanTest, we are able to significantly shorten our evaluation process, saving both time and money.”

We invite everyone interested in helping to share these new developments and findings, to join the webinar.

Webinar: Unfolding Cystic Fibrosis Research
DATE: Thursday, September 12, 2013
TIME: 1 p.m. ET
DURATION: 1 hour

About ChanTest – The Ion Channel Expert

ChanTest’s mission is to serve the drug discovery and development needs of customers worldwide with high-value solutions for ion channel and GPCR biology. Since its inception in 1998, the CRO has tested compounds for more than 300 global pharmaceutical and biotechnology companies, and partners with them to speed the drug development process for the release of better, safer drugs.

ChanTest offers integrated ion channel and GPCR services (GLP and non-GLP) and reagents; the company’s library of validated ion channel cell lines, and nonclinical cardiac risk assessment service portfolio, is the most comprehensive commercially available today.

Because of ChanTest’s seminal role in the nonclinical cardiac safety field, along with the company’s uncompromising commitment to quality, ChanTest has been named the “most trusted and most used fee-for-service provider” for ion channel screening in independent surveys since 2006. ChanTest is based in Cleveland, Ohio. For more information, e-mail info(at)chantest(dot)com or visit to learn more about what we do.

To learn more about the ChanTest® ChansPorter™ Assays, click here.

14656 Neo Parkway
Cleveland, Ohio 44128
1-877-828-1777 Toll Free
1-216-332-1665 Tel
1-216-332-1706 Fax

Contact for Media Inquiries:
Chris Mathes, Ph.D., M.B.A.
Chief Commercial Officer

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. ChanTest Announces Third User Meeting: Partnerships in Drug Discovery
2. ChanTest Announces ChansPorter™ Assays to Accelerate Drug Development for Cystic Fibrosis Patients
3. Diet Doc Announces Improved Medical Diet Plans That Help Patients Avoid Excess Weight Gain, Now Found to Possibly be Caused by Antidepressant Medication
4. AxoGen, Inc. Announces Exercise of Over-Allotment Option
5. Bell Lifestyle Products Inc. Announces the Launch of Two New Natural Health Products
6. Contract Research Organization WCCT Global Announces Acquisition of Early Phase Ophthalmology and Aesthetics Capabilities
7. Native Remedy; Zion Health Announces Natural Hair Products for Color Treated Hair: Adama Minerals Now Available at Whole Foods Market in West Hartford, CT
8. Northern New Jersey Water Softener Company Announces Water Softener Trade-In Deal for Home and Business Owners
9. ITAZ Technologies Announces a Discount on its Sohodox Document Software at BitsDuJour
10. American Telemedicine Association Announces Insurance Brokerage Partnership with HUB Healthcare Solutions
11. Game Ready(R) Announces Launch of Kineta(TM) and Kineta(TM) Cool Post-Op Knee Braces
Post Your Comments:
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... YORK , June 23, 2016 ... waters, but it continues to present great opportunities to ... companies for today: Intrexon Corp. (NYSE: XON ... Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), and ... more about these stocks and receive your complimentary trade ...
Breaking Medicine Technology: